BUZZ-OZK Bank shares rise after announcing extension details for San Diego loan
路透社2026/10/12 15:56October 12 - ** Regional lender Bank OZK (OZK.O) shares rose 2.4% to $45.48
** OZK has extended the maturity date of its largest credit commitment—a $915 million loan secured by a San Diego project—to December 2029 (link)
** With the extension of the maturity date, the project sponsor and its partners will inject an additional $100 million in capital into the project
** "Overall, we view this as positive for OZK, as the extension and the sponsor’s capital injection alleviate NT (near-term) maturity and liquidity concerns," said Piper Sandler analysts
** "While the extension itself was largely anticipated, the added positive was the $100 million incremental sponsor equity, which we believe reduces the likelihood of a near-term risk rating downgrade as the third-quarter earnings report approaches," said TD Cowen analysts
** Out of 10 brokerages, 3 rate the stock "buy" or higher, 5 "hold," and 2 "sell" or lower; the median price target is $51.50 — LSEG data
** As of the previous session’s close, OZK shares are down 3.5% for the year
(To facilitate non-English speakers, Reuters has automated the translation of its reports into several other languages. Because automated translation may be inaccurate or lack needed context, Reuters does not guarantee the accuracy of automated translation. Automated translation is provided solely for reader convenience. Reuters accepts no responsibility for any harm or loss arising from use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go
Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.
RBA Minutes: Case for rates to act promptly to keep inflation expectations anchored